FDA Warning: serious adverse reactions including tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects and exacerbation of myasthenia gravis
FDA Black Box Warning* added in 2008
(Additional FDA warnings after 2008 are referenced within the links below)
FDA Cipro Label 05/03/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019537s089,020780s046lbl.pdf#page=38
FDA Levaquin Label 06/28/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s069lbl.pdf#page=51
FDA Avelox 05/03/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021085s065,021277s061lbl.pdf#page=33
* the highest safety-related warning that medications can have assigned by the Food and Drug Administration
FDA Press Release 2016:
https://www.fda.gov/news-events/press-announcements/fda-updates-warnings-Fluoroquinolone-antibiotics
Multiple FDA Warnings & Articles:
https://www.fda.gov/search?s=+Fluoroquinolone&sort_bef_combine=rel_DESC
FQAD (Fluoroquinolone Associated Disability):
In 2015, after victim testimonies before the Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the FDA, a cluster of recognized symptoms became known as FQAD (Fluoroquinolone Associated Disability). Please note these symptoms do not include many of the severe common adverse effects continually reported in support groups by thousands living with this toxicity and yet to be fully acknowledged by any government entity.
Please note as of January 14, 2024, there is no medical billing code for FQAD
It is crucial that patients or doctors witnessing adverse effects file a report to the FDA. If you don't report it, this condition is deemed rare. You may file a report each year you continue to experience issues:
Your support will help fund current and future research
On your Zelle account, copy and paste our email address to transfer your donation to our foundation: fq100@protonmail.com
Copyright © 2020 - All Rights Reserved.
Powered by GoDaddy Website Builder